Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs... Show more
The RSI Oscillator for BMA moved out of oversold territory on September 22, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In of the 22 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on October 02, 2025. You may want to consider a long position or call options on BMA as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BMA just turned positive on September 23, 2025. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .
BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BMA entered a downward trend on September 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.878) is normal, around the industry mean (1.125). P/E Ratio (10.450) is within average values for comparable stocks, (20.601). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.828). Dividend Yield (0.026) settles around the average of (0.037) among similar stocks. P/S Ratio (1.255) is also within normal values, averaging (5.144).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
a regional bank
Industry RegionalBanks
A.I.dvisor indicates that over the last year, BMA has been closely correlated with GGAL. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if BMA jumps, then GGAL could also see price increases.
Ticker / NAME | Correlation To BMA | 1D Price Change % | ||
---|---|---|---|---|
BMA | 100% | +1.09% | ||
GGAL - BMA | 94% Closely correlated | +0.35% | ||
SUPV - BMA | 94% Closely correlated | +2.02% | ||
BBAR - BMA | 93% Closely correlated | +0.60% | ||
BSAC - BMA | 39% Loosely correlated | +0.49% | ||
SBNY - BMA | 38% Loosely correlated | -4.41% | ||
More |